Dan boards a plane heading towards India. He's part of a team of doctors that are volunteering to provide health support in one of the villages in one of India's states' rural areas.

Once the plane lands, Dan heads out and he and his peers are greeted by a welcoming committee. The team of doctors is notified that they'd be taken to the rural areas tomorrow, and the state has set up a welcome dinner tonight. The doctors are driven to a hotel, which also happens to be hosting their dinner.

The team takes a few hours to clean up and rest before heading to the dinner. As night approaches, they receive a custodian at their rooms who kindly requests them to make their way to the lobby. The doctors make their way to the lobby, where the hotel staff directs them to a small restaurant.

The restaurant is filled with various professionals from the healthcare industry; the state had invited a host of individuals related to the healthcare industry to the dinner. Dan makes his way to pick up a soda and he gets acquainted with Jen, a researcher at a pharmaceutical firm. The two strike a conversation and Dan runs over his purpose in India is to help a small village's residents.

Jen begins explaining her work and Dan can't help but raise his eyebrows in awe. Jen is working with a team of researchers to develop precision medicine for the same village where Dan will be volunteering. She explains that her team has received a fund to test the possibility of developing custom medication processes for incredibly low-income patients. But this mission could be a reality, she explains, with the aid of a new technology company.

Jen's company is utilizing Shivom's marketplace to develop precision medication for a host of villages across the world. The company has received funds from governments to develop medication optimized for the villages' residents. As the villages have small populations, they offer a good entry point for such a revolutionary step in medication.

With Shivom, the pharmaceutical, along with many other firms and researchers, is able to buy genomic data. The economies of scale created by this make precision drug development affordable. As genomic data can be bought by many, many enterprises, the average cost becomes affordable on an aggregate level.

Shivom is also offering the village residents the opportunity to sell their genomic data for an income stream. With Shivom, a distant village in India is able to receive medication optimized for its residents, and its residents have the ability to grow their income by selling their genomic data to firms.

The Takeaway

Blockchain projects that are decentralizing data markets certainly make way for individuals to drive an income. But one major impact they have as that they make data cheaper and vastly accessible.

In Shivom's case, the data at hand will be genomic data and this makes enhancements in the medical industry cheaper. While making precision medicine for a small village in rural India, as I discuss in the piece above, might be a bit of a stretch, it could be possible. Such a possibility is achievable if enough enterprises are willing to purchase genomic data, driving the overall price of genomic data on any particular ethnicity. I used a particular example for a state in India (in this piece) because one of Shivom's first partners is an Indian state named Andhra Pradesh.

Largescale adoption will be a journey, but this piece highlights a reality of the scale of availability of precision medicine achievable in the long run. Shivom is making way for better healthcare on a global scale.

Essential Links

🌐 Website: https://shivom.io/
💡 Whitepaper: https://shivom.io/files/Whitepaper.pdf
👨 ANN Thread: https://bitcointalk.org/index.php?topic=2365709.0
💻 Telegram: https://t.me/projshivom
⌚️ Token Sale: Presale Starts April 16

Connect with me:
https://bitcointalk.org/index.php?action=profile;u=1700741;sa=summary
https://steemit.com/@hatu – Follow for a new ICO analysis every day!
Twitter
Telegram Group – Keep up with ICOs